Home » Topics » Conferences

Conferences
RSS

Janssen optimizes new series of PDE2A inhibitors

Sep. 1, 2021

COL13A1 and KCNMA1 are downregulated in patients with Pompe disease

Sep. 1, 2021

Merck & Co. structure-based design efforts lead to new nucleoside PRMT5 inhibitors

Sep. 1, 2021

Biallelic THUMPD1 variants linked to syndromic intellectual developmental disorder

Sep. 1, 2021

Loss of fbn2b tied to cardiovascular manifestations overlapping with Marfan syndrome

Sep. 1, 2021

Discovery of CPL-302415 as promising preclinical candidate for SLE

Sep. 1, 2021

Novel oxidative-phosphorylation inhibitors with promising antitumor activity in vivo

Sep. 1, 2021

hsa-miR-34b-5p as novel diagnostic marker in male infertility

Aug. 31, 2021

Polymorphisms in the IRAK2 gene are associated with RA susceptibility

Aug. 31, 2021

New genes identified to cause nonsyndromic cleft palate

Aug. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...